Indo-Bangla Pharmaceuticals (DHA:IBP) Ending Cash Position: BDT0.00 Mil (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DHA:IBP Indo-Bangla Pharmaceuticals Ltd DHA:IBP
32 GF Score
Price BDT19.30
View Full Analysis

What is Indo-Bangla Pharmaceuticals Ending Cash Position?

Indo-Bangla Pharmaceuticals DHA:IBP -0.52% 32 Ending Cash Position is BDT0.00 Mil as of . 20. GuruFocus rates DHA:IBP with a GF Score™ of 32/100.

Indo-Bangla Pharmaceuticals's Ending Cash Position for the quarter that ended in . 20 was BDT0.00 Mil.

Indo-Bangla Pharmaceuticals Ending Cash Position Related Terms

Indo-Bangla Pharmaceuticals Ending Cash Position Historical Data

* Premium members only.

The historical data trend for Indo-Bangla Pharmaceuticals's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Indo-Bangla Pharmaceuticals Ending Cash Position Chart

Indo-Bangla Pharmaceuticals Annual Data
Trend
Ending Cash Position

Indo-Bangla Pharmaceuticals Semi-Annual Data
Ending Cash Position
DHA:IBP
32GF Score
Indo-Bangla Pharmaceuticals Ltd DHA:IBP
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Indo-Bangla Pharmaceuticals Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Indo-Bangla Pharmaceuticals's Ending Cash Position for the fiscal year that ended in . 20 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=+
=0.00

Indo-Bangla Pharmaceuticals's Ending Cash Position for the quarter that ended in . 20 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=+
=0.00

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of BDT0.00 Mil mean?
Indo-Bangla Pharmaceuticals (DHA:IBP) has a Ending Cash Position of BDT0.00 Mil as of . 20. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Indo-Bangla Pharmaceuticals and its competitors.
Is Indo-Bangla Pharmaceuticals' Ending Cash Position too high?
Indo-Bangla Pharmaceuticals' current Ending Cash Position is BDT0.00 Mil. Overall, Indo-Bangla Pharmaceuticals has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Indo-Bangla Pharmaceuticals' Ending Cash Position compare to ?
Indo-Bangla Pharmaceuticals' Ending Cash Position of BDT0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Drug Manufacturers company?
A good Ending Cash Position depends on the Drug Manufacturers industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Indo-Bangla Pharmaceuticals and its competitors. Indo-Bangla Pharmaceuticals's current Ending Cash Position is BDT0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Indo-Bangla Pharmaceuticals stock overvalued right now?
Indo-Bangla Pharmaceuticals (DHA:IBP) has a current Ending Cash Position of BDT0.00 Mil. The current Ending Cash Position is BDT0.00 Mil. Indo-Bangla Pharmaceuticals' overall GF Score™ is 32/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Indo-Bangla Pharmaceuticals (DHA:IBP), the current Ending Cash Position is BDT0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Indo-Bangla Pharmaceuticals Business Description

Comparable Companies
Address Ahmed Akbar Sobhan Road, Block B, Plot No. 183, 6th Floor, Bashundhara R/A, Baridhara, Dhaka, BGD, 1229
Indo-Bangla Pharmaceuticals Ltd is engaged in the manufacturing, marketing, and distribution of generic pharmaceutical products. The products of the company include human drugs dosages form such as tablets, capsules, syrup, oral saline, and suspension. The products of the company are sold in the domestic market.
32GF Score

Get the complete analysis for DHA:IBP

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT19.30
Price